Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for neuroprotection after subarachnoid hemorrhage
NCT02113176Phase 2Withdrawn
- Sponsor
- University at Buffalo
- Start
- Jan 2010
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in aneurysmal subarachnoid hemorrhage (SAH), sponsored by University at Buffalo. Planned start Jan 2010; status: withdrawn.
02
Drugs
minocycline
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02113176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113176.